Adial Pharmaceuticals, Inc. (ADIL)
NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
As of 10:36AM EDT. Market open.
| Previous close | 1.4200 |
| Open | 1.4200 |
| Bid | 1.2200 x 500 |
| Ask | 1.3500 x 100 |
| Day's range | 1.2907 - 1.4200 |
| 52-week range | 0.7700 - 14.0000 |
| Volume | |
| Avg. volume | 6,355,883 |
| Market cap | 5.464M |
| Beta (5Y monthly) | 1.41 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Zacks
Is Masimo (MASI) Outperforming Other Medical Stocks This Year?
Here is how Masimo (MASI) and Adial Pharmaceuticals, Inc. (ADIL) have performed compared to their sector so far this year.
- Zacks
All You Need to Know About Adial Pharmaceuticals, Inc. (ADIL) Rating Upgrade to Buy
Adial Pharmaceuticals, Inc. (ADIL) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
- Zacks
Adial (ADIL) Shares Up 43% in the Past Week: Here's Why
Adial (ADIL) shares rise 43% in the past week after the company announced positive regulatory updates on its only pipeline candidate, AD04, for the treatment of alcohol use disorder.
© 2024 Yahoo. All rights reserved.